Melanotan 2

Melanotan II (MT-2) is a synthetic peptide derived from the naturally occurring hormone α-MSH (alpha-melanocyte-stimulating hormone). It was originally developed for research into skin pigmentation and photoprotection. MT-2 acts primarily by stimulating melanocortin receptors, which play a role in melanin production, appetite regulation, and sexual function.

Although widely discussed in peptide communities, Melanotan II is not approved as a cosmetic tanning product in most countries and remains primarily a research compound.

How Melanotan II Works

MT-2 binds to several melanocortin receptors, particularly MC1R, which is involved in melanin synthesis within melanocytes.

Activation of these receptors may:

• Increase melanin production

• Darken skin pigmentation

• Enhance tanning response to UV exposure

• Potentially reduce susceptibility to sunburn

• Influence sexual arousal pathways through activity at other melanocortin receptors

Unlike traditional tanning methods, which rely solely on UV exposure to stimulate melanin production, MT-2 may increase pigmentation even with relatively limited sun exposure.

Potential Benefits

Enhanced Skin Pigmentation

The primary reason for interest in MT-2 is its ability to stimulate melanin production.

Potential effects may include:

• Faster tanning response

• Darker and more persistent pigmentation

• Increased baseline skin tone

• Reduced UV exposure required to achieve a tan

Photoprotection Research

Higher melanin levels may provide some protection against UV-induced skin damage. However, MT-2 should never be considered a replacement for sunscreen or proper sun protection practices.

Additional Observed Effects

Some users report:

• Increased libido

• Enhanced sexual arousal

• Appetite suppression

These effects are believed to result from activation of melanocortin receptors beyond those involved in pigmentation.

Side Effects

Side effects are relatively common, especially during the early stages of use.

Frequently reported side effects include:

• Nausea

• Facial flushing

• Fatigue

• Loss of appetite

• Headache

• Dizziness

• Increased body temperature

• Yawning

Skin-related effects may include:

• Darkening of freckles

• Darkening of moles

• Uneven pigmentation

• Increased visibility of existing pigmented lesions

Injection-related effects may include:

• Redness

• Mild swelling

• Local irritation

Dosing

There is no officially approved medical dosing guideline for Melanotan II.

Research and community protocols often involve:

Loading Phase

• Approximately 250–500 mcg daily

• Gradually increased depending on individual response and tolerability

Maintenance Phase

• Approximately 250–1,000 mcg administered periodically

• Frequency varies significantly between protocols

Because sensitivity differs considerably between individuals, gradual dose escalation is often used to minimize nausea and other adverse effects.

Important Considerations

MT-2 can significantly affect skin pigmentation and may darken freckles, moles, and other pigmented lesions. Individuals with a personal or family history of skin cancer should exercise particular caution.

Regular skin monitoring is advisable for anyone using compounds that influence melanin production.

The long-term safety profile of Melanotan II has not been fully established, and its use remains controversial in many jurisdictions.

Summary

Melanotan II (MT-2) is a synthetic melanocortin peptide that stimulates melanin production, leading to increased skin pigmentation and enhanced tanning response. Additional effects such as appetite suppression and increased libido have also been observed. Common side effects include nausea, flushing, fatigue, and darkening of freckles or moles. While MT-2 has attracted significant interest for cosmetic tanning purposes, it remains an investigational compound, and further research is required to fully understand its long-term safety and efficacy.